2023
DOI: 10.1016/j.rgmx.2021.09.002
|View full text |Cite
|
Sign up to set email alerts
|

Prevalencia y características clínico-epidemiológicas de una población mexicana con enfermedad del hígado graso asociada a disfunción metabólica: un estudio en población abierta

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…When referring to Mexican individuals, this rate increases to 33% [ 54 ]. When these prevalence data are updated to include the definition of MASLD, the prevalence increases to 41.3%, one of the highest in the world [ 55 ]. This problem is not limited to the adult population but also to childhood and adolescents [ 56 ].…”
Section: Discussionmentioning
confidence: 99%
“…When referring to Mexican individuals, this rate increases to 33% [ 54 ]. When these prevalence data are updated to include the definition of MASLD, the prevalence increases to 41.3%, one of the highest in the world [ 55 ]. This problem is not limited to the adult population but also to childhood and adolescents [ 56 ].…”
Section: Discussionmentioning
confidence: 99%